IONIS PHARMACEUTICALS INC's ticker is IONS and the CUSIP is 462222100. A total of 325 filers reported holding IONIS PHARMACEUTICALS INC in Q1 2022. The put-call ratio across all filers is 0.84 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $7,512,342 | +14.1% | 165,616 | +3.3% | 1.92% | +30.3% |
| Q2 2023 | $6,581,253 | +25.7% | 160,401 | +9.5% | 1.47% | +16.1% |
| Q1 2023 | $5,233,801 | -2.0% | 146,441 | +3.6% | 1.27% | +3.9% |
| Q4 2022 | $5,339,658 | -26.5% | 141,373 | -13.9% | 1.22% | -34.8% |
| Q3 2022 | $7,264,000 | +18.6% | 164,223 | -0.7% | 1.87% | +36.6% |
| Q2 2022 | $6,125,000 | -12.2% | 165,439 | -12.2% | 1.37% | -9.7% |
| Q1 2022 | $6,980,000 | +9.5% | 188,439 | -10.1% | 1.52% | +1.2% |
| Q4 2021 | $6,376,000 | -28.0% | 209,537 | -20.6% | 1.50% | -15.1% |
| Q3 2021 | $8,850,000 | -15.8% | 263,870 | +0.1% | 1.76% | -5.2% |
| Q2 2021 | $10,511,000 | -48.5% | 263,488 | -42.0% | 1.86% | -50.2% |
| Q1 2021 | $20,419,000 | +12.5% | 454,150 | +41.5% | 3.74% | +8.3% |
| Q4 2020 | $18,149,000 | +61.8% | 320,992 | +35.8% | 3.45% | +35.3% |
| Q3 2020 | $11,214,000 | +0.1% | 236,342 | +24.4% | 2.55% | +10.4% |
| Q2 2020 | $11,201,000 | -14.0% | 189,981 | -31.0% | 2.31% | -16.7% |
| Q1 2020 | $13,025,000 | -0.9% | 275,481 | +26.6% | 2.78% | +31.9% |
| Q4 2019 | $13,147,000 | +66.9% | 217,635 | +65.5% | 2.11% | +58.2% |
| Q3 2019 | $7,879,000 | -6.8% | 131,514 | 0.0% | 1.33% | -2.1% |
| Q2 2019 | $8,452,000 | -55.4% | 131,514 | -43.7% | 1.36% | -55.3% |
| Q1 2019 | $18,971,000 | -7.5% | 233,714 | -38.4% | 3.04% | -11.8% |
| Q4 2018 | $20,512,000 | +96.4% | 379,421 | +87.4% | 3.45% | +110.7% |
| Q3 2018 | $10,442,000 | -17.4% | 202,434 | -33.2% | 1.64% | -22.0% |
| Q2 2018 | $12,636,000 | +4.8% | 303,240 | +10.9% | 2.10% | -3.4% |
| Q1 2018 | $12,056,000 | +285.9% | 273,500 | +340.4% | 2.17% | +313.9% |
| Q4 2017 | $3,124,000 | – | 62,100 | – | 0.52% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Tweedy, Browne Co LLC | 3,541,136 | $133,749 | 7.12% |
| Bellevue Group AG | 9,743,900 | $368,027,103 | 4.88% |
| M28 Capital Management LP | 126,300 | $4,770,351 | 4.55% |
| Sicart Associates LLC | 246,258 | $9,301,165 | 3.28% |
| Camber Capital Management LP | 1,925,000 | $72,707 | 2.49% |
| Privium Fund Management B.V. | 148,807 | $5,557,941 | 2.11% |
| Deep Track Capital, LP | 1,205,773 | $45,542,046 | 1.91% |
| BVF INC/IL | 1,121,809 | $42,370,726 | 1.79% |
| Orbimed Advisors | 1,993,600 | $75,298,272 | 1.44% |
| Parkman Healthcare Partners LLC | 141,115 | $5,329,914 | 1.42% |